Fabiani, Emiliano
 Distribuzione geografica
Continente #
NA - Nord America 3.121
EU - Europa 2.201
AS - Asia 1.739
SA - Sud America 303
Continente sconosciuto - Info sul continente non disponibili 59
AF - Africa 56
OC - Oceania 12
Totale 7.491
Nazione #
US - Stati Uniti d'America 3.043
DE - Germania 871
SG - Singapore 722
CN - Cina 556
SE - Svezia 398
BR - Brasile 247
UA - Ucraina 174
FR - Francia 162
IT - Italia 158
VN - Vietnam 120
PL - Polonia 118
GB - Regno Unito 69
IE - Irlanda 69
IN - India 65
FI - Finlandia 47
ID - Indonesia 47
RU - Federazione Russa 42
JP - Giappone 37
CA - Canada 36
HK - Hong Kong 35
BD - Bangladesh 32
MX - Messico 21
IQ - Iraq 18
TR - Turchia 18
NL - Olanda 17
ZA - Sudafrica 16
PK - Pakistan 15
CO - Colombia 14
AR - Argentina 13
KR - Corea 12
AU - Australia 11
AT - Austria 10
BE - Belgio 10
CI - Costa d'Avorio 9
CZ - Repubblica Ceca 8
ES - Italia 8
IR - Iran 8
CL - Cile 7
EC - Ecuador 7
GR - Grecia 7
JO - Giordania 7
LT - Lituania 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
MA - Marocco 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
BG - Bulgaria 5
EG - Egitto 5
DZ - Algeria 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
KE - Kenya 4
PH - Filippine 4
SA - Arabia Saudita 4
TH - Thailandia 4
BB - Barbados 3
CH - Svizzera 3
CR - Costa Rica 3
HR - Croazia 3
MY - Malesia 3
NO - Norvegia 3
PY - Paraguay 3
TN - Tunisia 3
AO - Angola 2
BO - Bolivia 2
ET - Etiopia 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
PE - Perù 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AL - Albania 1
AW - Aruba 1
BW - Botswana 1
BZ - Belize 1
DO - Repubblica Dominicana 1
EU - Europa 1
FJ - Figi 1
GE - Georgia 1
GH - Ghana 1
IS - Islanda 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
ME - Montenegro 1
MK - Macedonia 1
MR - Mauritania 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SI - Slovenia 1
Totale 7.433
Città #
Singapore 429
Chandler 352
Ashburn 284
San Jose 240
Jacksonville 121
Warsaw 113
Los Angeles 96
Beijing 94
Dearborn 92
Houston 86
Nanjing 86
Chicago 81
San Mateo 79
New York 74
Ann Arbor 72
Dublin 64
Wilmington 56
Woodbridge 56
Buffalo 50
Fairfield 45
Lauterbourg 42
Jakarta 41
Milan 41
Nürnberg 41
Ho Chi Minh City 40
Dallas 39
Bremen 38
Hanoi 33
Hong Kong 33
Munich 33
Nanchang 32
Hefei 31
Seattle 31
São Paulo 30
Lawrence 28
Salt Lake City 28
Boston 27
Moscow 27
Redwood City 27
Frankfurt am Main 25
Tokyo 25
Marseille 22
Cattolica 21
Shanghai 21
The Dalles 19
Guangzhou 18
Hangzhou 17
Kunming 17
Chatsworth 16
Santa Clara 16
Leawood 14
Montreal 14
Orem 14
Auburn Hills 13
Changsha 13
London 13
Tampa 13
Tianjin 13
Zhengzhou 13
Shenyang 12
Atlanta 11
Baghdad 11
Cambridge 11
Elk Grove Village 11
Paris 11
Princeton 11
Pune 11
Council Bluffs 10
Helsinki 10
Izmir 10
Jiaxing 10
Mountain View 10
Rome 10
Abidjan 9
Boardman 9
Brussels 9
Denver 9
University Park 9
Augusta 8
Brooklyn 8
Fremont 8
Haiphong 8
Hebei 8
Jinan 8
Kent 8
Mexico City 8
Miami 8
Rio de Janeiro 8
Washington 8
Amman 7
Lancaster 7
Lanzhou 7
Las Vegas 7
Nuremberg 7
Belo Horizonte 6
Edinburgh 6
Enterprise 6
Johannesburg 6
Phoenix 6
Seoul 6
Totale 3.902
Nome #
5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature 437
Fanconi anemia gene variants in therapy-related myeloid neoplasms 331
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 305
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 271
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 245
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 244
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 243
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 220
Why methylation is not a marker predictive of response to hypomethylating agents 203
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 200
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 194
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 194
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 193
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 193
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 193
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 188
Epigenetic changes in therapy-related MDS/AML 187
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 187
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 178
Clonal evolution in therapy-related neoplasms 178
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 177
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 174
Endothelial progenitor cell dysfunction in myelodysplastic syndromes: possible contribution of a defective vascular niche to myelodysplasia 174
Similarities and differences between therapy-related and elderly acute myeloid leukemia 172
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 170
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 166
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 158
PU.1 and CEBPA expression in acute myeloid leukemia. 158
The BCL2L10 Leu21Arg variant and risk of therapy-related myeloid neoplasms and de novo myelodysplastic syndromes 151
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine 150
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 148
Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. 145
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 138
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 132
Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome 129
Therapy-related myeloid neoplasms: Clinical perspectives 121
Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapy 114
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells 90
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 83
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 81
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis 76
Totale 7.491
Categoria #
all - tutte 25.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.424


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022351 0 40 5 11 31 19 5 76 17 40 51 56
2022/2023960 143 145 78 181 56 100 36 93 76 3 36 13
2023/2024380 21 96 10 15 18 95 5 15 5 7 45 48
2024/2025973 19 22 71 22 80 15 47 36 112 59 384 106
2025/20262.091 299 50 111 199 363 172 360 103 212 143 52 27
2026/2027216 71 145 0 0 0 0 0 0 0 0 0 0
Totale 7.491